CanOmix

Genetic Markers for Medical Cannabis

Startup

CanOmix is a Meitar-based startup in the Health Tech & Life Sciences sector, established in 2015. Genetic Markers for Medical Cannabis . CanOmix was founded by Noam Chehanovsky. The company has 1-10 employees. Core technologies: Biologicals, Genes.

The company follows a B2B business model. Product stage: Released.

3
Team
2015
Founded
Sector & Technology
Agriculture & Food TechnologiesAg TechGenetics & InputHealth Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisBiologicalsGenes
At a Glance
Founders
In the News

1 article covered by sources including www.jpost.com.

www.jpost.com · Mar 8, 2016
http://www.jpost.com/Not-Just-News/Podcast/Cannabis-start-ups-pave-the-way-for-the-rise-of-a-Spark-Up-Nation-447234
Read article ↗
Frequently Asked Questions
What does CanOmix do?

CanOmix develops science-based technologies designed to bring increased accuracy, efficiency, and safety to medical cannabis cultivation. CanOmix has developed genetic markers to identify the medical potential of cannabis plants. These markers are integrated into the company's cannabis-breeding technology, leading to savings in time, money, space, and manpower. The company's R&D center, located in Israel, collaborates with academic and commercial partners worldwide.

Who founded CanOmix?

CanOmix was founded in 2015 by Noam Chehanovsky (Founder & CEO).

What sector is CanOmix in?

CanOmix operates in Agriculture & Food Technologies, Ag Tech, Genetics & Input, Health Tech & Life Sciences, Pharma & Medical Biotechnology, Medical Cannabis, with core technologies in Biologicals, Genes. Target customers: Agriculture & Food, Crops, Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.

Where is CanOmix located?

CanOmix is based in Ktsi'ot St 8, Meitar, Israel, South District.

View Full Profile Classic View Website ↗